NS100

The NS100 is a percutaneous electrical nerve stimulation (PENS) device designed to provide effective and lasting pain relief for patients suffering from diabetic neuropathy.  This FDA-cleared Class II medical device delivers low-level electrical pulses to nerve endings in the outer ear over a 20-day period.

Minally Invasive: The device is applied in a clinic or outpatient setting using only a topical anesthetic.

Quick Proedure: The application takes about 20-30 minutes.

Long- Lasting Relief: Patients often experience significant pain relief for up to six months or more.

Daily Activities: The device has little to no impact on daily activities.

If you or someone you know is dealing with diabetic neuropath, this could be a promising option to explore. Studies have shown that PENS device like the NS100 can significantly reduce pain intensity and improve quality of life for patients with diabetic neuropathy. Overall, the NS100 is a highly effective and minimally invasive option for managing diabetic neuropathy, offering comparable benefits to other advanced neurostimulation treatments.

In a time of Opioid Crisis, it is imperative to find ways of treating chronic pain without the use of narcotics.  The NeuroSolutions 100 neurostimulation therapy proves to dramatically decrease pain for 2 to 6 months, sometimes longer. With neurostimulation, many patients have felt their pain levels tremendously reduced after just a few days.